Part-Time

Home Infusion Nurse

Updated on 8/1/2026

Option Care Health

Option Care Health

1,001-5,000 employees

Largest independent home infusion therapy provider

Compensation Overview

$40.78 - $67.97/hr

+ 401(k) match + Award/Recognition Programs

Troy, MI, USA

In Person

Travel up to 100% of the time for business purposes.

Category
Medical, Clinical & Veterinary (1)
Required Skills
CPR
Medication Administration
Patient Care
Electronic Health Records (EHR)
HIPAA
Patient Education

Get referred to Option Care Health

See people who can refer or advise you

Requirements
  • An active and unrestricted registered nurse license in the state of practice is required.
  • A minimum of 1 year of nursing experience is required.
  • Current CPR certification is required.
  • Demonstrated competency in patient care standards and infusion skill sets applicable to agency programs and service needs is required.
  • Required licensure to operate a motor vehicle in the state of practice, access to a vehicle for business travel, and proof of liability insurance are required.
  • Basic knowledge of computer operating systems and software applications, with the ability to use nursing technology tools to communicate and document care, is required.
  • The role requires the ability to lift up to 50 pounds, with a maximum lifting capacity of 75 pounds, and to perform the listed physical activities.
  • The role involves potential occupational exposure to blood, body fluids, hazardous substances, needles, sharps, chemicals, weather elements, animals, secondhand smoke or vapor, and unpredictable home environments.
  • The role requires closed-toe shoes, a facemask, goggles, a gown or gloves, and a functioning communication device for routine and emergency situations.
  • Willingness to travel up to 100% of the time for business purposes is required.
Responsibilities
  • Initiate, develop, and implement intermediate nursing plans of care and treatments, evaluate patient progress toward goals, provide direct patient care, perform treatments, administer medications, and educate patients and families or caregivers.
  • Modify the plan of treatment in response to changing patient status or physician orders to achieve established or revised patient care goals.
  • Assess patient needs and physical status at each skilled visit through health data access and patient interviews, and re-evaluate needs through physical reassessment, response to therapy, and supplemental physician orders.
  • Obtain and clarify physician orders for plan-of-treatment revisions, promptly inform physicians of significant changes in patient condition, and provide written summaries to physicians within supplemental orders.
  • Provide training and mentorship to Infusion Nurse I employees as needed to ensure patient safety and compliance.
  • Provide effective, patient-centered teaching to patients and families to achieve independence with prescribed therapy and care needs.
  • Communicate with the clinical team, medical providers, patients, and families or caregivers to facilitate continuity of care.
  • Prepare clinical documentation in real time during visits and submit it to the nursing department within established timelines for billing optimization.
  • Complete documentation legibly and apply approved abbreviations and documentation error-correction practices according to policy.
  • Coordinate discharge planning, prepare discharge summaries with patient instructions, and report patient care needs, progress, and goals when transferring care.
  • Comply with agency operations, company policies and procedures, professional standards, applicable local, state, and federal regulations and guidelines, and accreditation standards.
  • Use computers and automation technologies to validate plan-of-treatment orders, communicate care provided, and follow the assigned visit schedule.
  • Respond promptly and appropriately to patient requests and initiate emergency procedures as necessary.
  • Maintain ethical and professional conduct and accountability for independent practice.
  • Safeguard confidential patient and proprietary company information in accordance with legal and ethical guidelines and HIPAA regulations.
  • Explain the company's scope of services and instruct patients about related financial obligations for care and service charges.
  • Complete required training modules, in-services, and continuing education to maintain competency and professional licensure.
  • Provide oversight and coordination of paraprofessionals in the home setting and act as supervisor in the absence of the supervisor or nurse manager when applicable and permitted by regulations.
  • Participate in multidisciplinary team conferences and provide precepting, training, and mentoring for nurse orientation, onboarding, and supervisory activities as assigned.
  • Participate in nursing department on-call responsibilities.
  • Insert PICC lines or midlines per physician order when applicable.
  • Troubleshoot and declot obstructed central-line catheters when applicable.
  • Monitor PICC lines or midlines and educate patients on line-infection prevention and routine care when applicable.
  • Perform other related duties as directed by the supervisor.
Desired Qualifications
  • A Bachelor of Science in Nursing from an accredited school of nursing is preferred.
  • One to two years of previous infusion nursing experience is preferred.

Option Care Health delivers infusion therapies at home and other alternate-site locations across the United States, supported by over 7,000 teammates including about 4,500 clinicians. Clinicians visit patients at home or approved sites to administer therapies, manage care, and coordinate with care teams under strong clinical leadership and national scale. It stands out as the largest independent infusion provider with nationwide reach and a robust clinical workforce, enabling scalable home and alternate-site infusion rather than hospital-only care. The goal is to elevate standards of care and reimagine the infusion care experience by expanding access, improving outcomes, and delivering compassionate, clinically driven service.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Norfolk, Virginia

Founded

1979

Get referred to Option Care Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 adjusted EBITDA rose 3% to $117.5 million.
  • Operating cash flow totaled $184 million in Q2.
  • Management repurchased $150 million of shares, nearly 5% outstanding.

What critics are saying

  • CID pressure cuts 2026 revenue about 600 basis points.
  • CID headwinds reduce gross profit by $55 million.
  • Net debt leverage of 2.1x limits flexibility during reimbursement shocks.

What makes Option Care Health unique

  • Largest independent U.S. home and alternate-site infusion provider.
  • Q2 2026 revenue reached $1.442 billion, beating expectations.
  • Acute therapies and ambulatory clinics drive growth beyond CID weakness.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Time Off

Bonding Time Off

401(k) Retirement Plan

401(k) Company Match

Health Savings Account/Flexible Spending Account

Flexible Spending Accounts

Tuition Reimbursement

Family Support

Mental Health Support

Company Paid Life Insurance

Award/Recognition Programs

Company News

Simply Wall St
Apr 4th, 2026
Option Care Health expands credit facility to $850M, boosts buyback to $1B

Option Care Health has expanded its revolving credit facility by $450 million to $850 million and increased its share repurchase authorisation to $1 billion, whilst reaffirming its 2026 guidance. The moves strengthen liquidity and signal management confidence in cash generation. The expanded buyback and credit facility provide greater flexibility for growth investments and capital returns, though near-term focus remains on executing guidance and managing reimbursement pressures. The company's narrative projects $7 billion revenue and $302.2 million earnings by 2029, implying 7.5% annual revenue growth. Analyst fair value estimates range widely from $3.66 to $40.09 per share, with the upper estimate suggesting 46% upside from current prices.

MicroCare
Mar 9th, 2026
MicroCare Medical welcomes Matt Lingenfelter as national sales manager, healthcare.

MicroCare Medical welcomes Matt Lingenfelter as national sales manager, healthcare. March 09, 2026 MicroCare Medical is pleased to welcome Matt Lingenfelter as national sales manager, healthcare. With more than 20 years of experience in healthcare sales and leadership, Matt will help drive national growth and strengthen partnerships for the MicroCare Medical instrument care and infection prevention solutions. In this role, Matt will guide healthcare sales strategy across the U.S., focusing on expanding key accounts, building strong distributor relationships, and supporting the sales team. He will also work closely with marketing, operations, and product development to ensure MicroCare continues delivering solutions that meet the evolving needs of healthcare professionals. Before joining MicroCare, Matt held leadership roles with Option Care Health, Belimed, and Aesculap, where he developed deep expertise in surgical instrumentation, endoscopic technologies, and hospital system support. "Matt's experience and understanding of healthcare systems make him a fantastic addition to our team," said Ray Bellavance, vice president of global sales and marketing at MicroCare. "We're excited to have him help grow our healthcare business and strengthen partnerships across the country."

Yahoo Finance
Feb 27th, 2026
Option Care Health posts 13% revenue growth despite $25M–35M Stelara biosimilar headwind

Option Care Health reported a 13% revenue increase in Q4 2025, with acute therapies growing in the mid-teens and chronic therapies in the low double digits. The company served over 315,000 unique patients and improved operational efficiency, with 40% of claims now processed without human intervention. For 2026, the company issued revenue guidance of $5.8 billion to $6 billion, incorporating a 400 basis point headwind from Stelara biosimilar conversions and Inflation Reduction Act impacts. Adjusted EBITDA is projected at $480 million to $505 million, accounting for a $25 million to $35 million gross profit headwind from Stelara transitions. Operating cash flow is expected to exceed $340 million, representing over 30% growth. The company plans to launch at least two new pharmaceutical manufacturer programmes and expand its infusion clinic model to support higher-acuity therapies.

PREEMPT, Inc
Sep 30th, 2025
EEOC Sues Option Care Health, Inc. for Pregnancy Discrimination

EEOC sues Option Care Health, Inc. for pregnancy discrimination.

Option Care Health
Aug 7th, 2025
Quince Therapeutics Selects Option Care Health as Specialty Infusion Therapy Provider for Administration of Lead Asset eDSP

Quince Therapeutics selects Option Care Health as specialty infusion therapy provider for administration of lead asset eDSP.